https://news.medxy.ai/brain-imaging-biomarkers-and-cognitive-outcomes-in-a-multidomain-lifestyle-intervention-the-pointer-imaging-ancillary-study/Medxy AIen2026-06-17T11:20:34-07:00Brain Imaging Biomarkers and Cognitive Outcomes in a Multidomain Lifestyle Intervention: The POINTER Imaging Ancillary Study https://news.medxy.ai/zh/%e7%94%b2%e7%8a%b6%e8%85%ba%e6%bf%80%e7%b4%a0%e6%88%96%e4%b8%baadpkd%e5%b8%a6%e6%9d%a5%e6%96%b0%e7%9a%84%e6%b2%bb%e7%96%97%e4%b8%8e%e9%a2%84%e5%90%8e%e8%a7%86%e8%a7%92/Medxy AIzh2026-06-17T10:59:56-07:00甲状腺激素或为ADPKD带来新的治疗与预后视角 https://news.medxy.ai/ja/adpkd%e3%81%ab%e6%96%b0%e3%81%9f%e3%81%aa%e5%8f%af%e8%83%bd%e6%80%a7%ef%bc%9a%e7%94%b2%e7%8a%b6%e8%85%ba%e3%83%9b%e3%83%ab%e3%83%a2%e3%83%b3%e3%81%8c%e4%ba%88%e5%be%8c%e4%ba%88%e6%b8%ac%e3%81%a8/Medxy AIja2026-06-17T10:59:33-07:00ADPKDに新たな可能性：甲状腺ホルモンが予後予測と治療に光を当てる https://news.medxy.ai/vi/hormone-tuyen-giap-co-the-mo-ra-huong-tien-luong-va-dieu-tri-moi-trong-adpkd/Medxy AIvi2026-06-17T10:59:02-07:00Hormone tuyến giáp có thể mở ra hướng tiên lượng và điều trị mới trong ADPKD https://news.medxy.ai/thyroid-hormones-may-offer-a-new-therapeutic-and-prognostic-angle-in-adpkd/Medxy AIen2026-06-17T10:57:17-07:00Thyroid Hormones May Offer a New Therapeutic and Prognostic Angle in ADPKD https://news.medxy.ai/time-restricted-eating-vs-dietetic-guidance-for-glycaemic-outcomes-in-adults-at-risk-of-type-2-diabetes/Medxy AIen2026-06-17T10:46:15-07:00Time-Restricted Eating vs Dietetic Guidance for Glycaemic Outcomes in Adults at Risk of Type 2 Diabetes https://news.medxy.ai/zh/%e5%a6%8a%e5%a8%a0%e6%9c%9f%e7%b3%96%e5%b0%bf%e7%97%85%e4%bc%9a%e5%a2%9e%e5%8a%a0%e6%97%a5%e5%90%8e%e7%99%8c%e7%97%87%e9%a3%8e%e9%99%a9%e5%90%97%ef%bc%9f%e6%95%b4%e4%bd%93%e7%bb%93%e6%9e%9c%e4%bb%a4/Medxy AIzh2026-06-17T10:38:01-07:00妊娠期糖尿病会增加日后癌症风险吗？整体结果令人安心，但肾癌信号值得警惕 https://news.medxy.ai/ja/%e5%a6%8a%e5%a8%a0%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%a8%e3%81%9d%e3%81%ae%e5%be%8c%e3%81%ae%e3%81%8c%e3%82%93%e3%83%aa%e3%82%b9%e3%82%af%ef%bc%9a%e5%85%a8%e4%bd%93%e3%81%a8%e3%81%97%e3%81%a6%e3%81%af/Medxy AIja2026-06-17T10:37:32-07:00妊娠糖尿病とその後のがんリスク：全体としては安心材料、ただし腎がんには注意のシグナル https://news.medxy.ai/vi/dai-thao-duong-thai-ky-va-nguy-co-ung-thu-ve-sau-ket-qua-nhin-chung-yen-tam-nhung-xuat-hien-tin-hieu-ung-thu-than/Medxy AIvi2026-06-17T10:37:06-07:00Đái tháo đường thai kỳ và nguy cơ ung thư về sau: kết quả nhìn chung yên tâm, nhưng xuất hiện tín hiệu ung thư thận https://news.medxy.ai/gestational-diabetes-and-later-cancer-risk-reassuring-overall-results-but-a-kidney-cancer-signal-emerges/Medxy AIen2026-06-17T10:35:56-07:00Gestational Diabetes and Later Cancer Risk: Reassuring Overall Results, but a Kidney Cancer Signal Emerges https://news.medxy.ai/publicly-funded-intermittently-scanned-continuous-glucose-monitoring-is-linked-to-fewer-hospitalizations-in-insulin-treated-type-2-diabetes/Medxy AIen2026-06-17T10:34:38-07:00Publicly Funded Intermittently Scanned Continuous Glucose Monitoring Is Linked to Fewer Hospitalizations in Insulin-Treated Type 2 Diabetes https://news.medxy.ai/vi/dd-cfdna-dau-an-sinh-hoc-tien-luong-trong-thai-ghep-tim-nang-tu-phat-hien-den-phan-tang-nguy-co/Medxy AIvi2026-06-17T10:29:04-07:00dd-cfDNA: dấu ấn sinh học tiên lượng trong thải ghép tim nặng, từ phát hiện đến phân tầng nguy cơ https://news.medxy.ai/donor-derived-cell-free-dna-as-a-prognostic-biomarker-in-severe-cardiac-allograft-rejection-from-detection-to-risk-stratification/Medxy AIen2026-06-17T10:27:11-07:00Donor-Derived Cell-Free DNA as a Prognostic Biomarker in Severe Cardiac Allograft Rejection: From Detection to Risk Stratification https://news.medxy.ai/tirzepatide-vs-dulaglutide-new-post-hoc-surpass-cvot-data-point-to-broader-cardiorenal-benefit/Medxy AIen2026-06-17T10:22:46-07:00Tirzepatide vs Dulaglutide: New Post Hoc SURPASS-CVOT Data Point to Broader Cardiorenal Benefit https://news.medxy.ai/postoperative-atrial-fibrillation-after-cardiac-surgery-common-variably-treated-and-linked-to-worse-1-year-outcomes/Medxy AIen2026-06-17T10:14:36-07:00Postoperative Atrial Fibrillation After Cardiac Surgery: Common, Variably Treated, and Linked to Worse 1-Year Outcomes https://news.medxy.ai/vi/rung-nhi-sau-phau-thuat-tim-thuong-gap-xu-tri-bien-thien-va-lien-quan-voi-ket-cuc-xau-hon-sau-1-nam/Medxy AIvi2026-06-17T10:13:46-07:00Rung nhĩ sau phẫu thuật tim: thường gặp, xử trí biến thiên và liên quan với kết cục xấu hơn sau 1 năm https://news.medxy.ai/10-year-randomized-outcomes-of-transcatheter-or-surgical-aortic-valve-replacement-in-intermediate-risk-aortic-stenosis-what-partner-2a-adds-to-the-long-term-tavr-evidence-base/Medxy AIen2026-06-17T09:59:42-07:0010-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis: What PARTNER 2A Adds to the Long-Term TAVR Evidence Base https://news.medxy.ai/galectin-3-regulates-smooth-muscle-contraction-and-blood-pressure-by-modulating-cav1-2-channel-function/Medxy AIen2026-06-17T09:53:58-07:00Galectin-3 Regulates Smooth Muscle Contraction and Blood Pressure by Modulating CaV1.2 Channel Function https://news.medxy.ai/ja/%e6%80%a5%e6%80%a7%e3%82%81%e3%81%be%e3%81%84%e5%be%8c%e3%81%ae%e3%83%87%e3%82%b8%e3%82%bf%e3%83%ab%e5%89%8d%e5%ba%ad%e3%83%aa%e3%83%8f%e3%83%93%e3%83%aa%e3%83%86%e3%83%bc%e3%82%b7%e3%83%a7%e3%83%b3-2/Medxy AIja2026-06-16T10:04:00-07:00急性めまい後のデジタル前庭リハビリテーション：優越性を示さなかった試験から読めること https://news.medxy.ai/vi/phuc-hoi-chuc-nang-tien-dinh-so-sau-chong-mat-cap-y-nghia-cua-mot-thu-nghiem-khong-chung-minh-duoc-uu-the-2/Medxy AIvi2026-06-16T10:03:53-07:00Phục hồi chức năng tiền đình số sau chóng mặt cấp: ý nghĩa của một thử nghiệm không chứng minh được ưu thế https://news.medxy.ai/zh/%e6%80%a5%e6%80%a7%e7%9c%a9%e6%99%95%e5%90%8e%e7%9a%84%e6%95%b0%e5%ad%97%e5%8c%96%e5%89%8d%e5%ba%ad%e5%ba%b7%e5%a4%8d%ef%bc%9a%e4%b8%80%e9%a1%b9%e9%98%b4%e6%80%a7%e4%bc%98%e6%95%88%e6%80%a7%e8%af%95-2/Medxy AIzh2026-06-16T10:03:46-07:00急性眩晕后的数字化前庭康复：一项阴性优效性试验意味着什么 https://news.medxy.ai/ja/%e6%80%a5%e6%80%a7%e3%82%81%e3%81%be%e3%81%84%e5%be%8c%e3%81%ae%e3%83%87%e3%82%b8%e3%82%bf%e3%83%ab%e5%89%8d%e5%ba%ad%e3%83%aa%e3%83%8f%e3%83%93%e3%83%aa%e3%83%86%e3%83%bc%e3%82%b7%e3%83%a7%e3%83%b3/Medxy AIja2026-06-16T00:58:10-07:00急性めまい後のデジタル前庭リハビリテーション：優越性を示さなかった試験から読めること https://news.medxy.ai/vi/phuc-hoi-chuc-nang-tien-dinh-so-sau-chong-mat-cap-y-nghia-cua-mot-thu-nghiem-khong-chung-minh-duoc-uu-the/Medxy AIvi2026-06-16T00:58:03-07:00Phục hồi chức năng tiền đình số sau chóng mặt cấp: ý nghĩa của một thử nghiệm không chứng minh được ưu thế https://news.medxy.ai/zh/%e6%80%a5%e6%80%a7%e7%9c%a9%e6%99%95%e5%90%8e%e7%9a%84%e6%95%b0%e5%ad%97%e5%8c%96%e5%89%8d%e5%ba%ad%e5%ba%b7%e5%a4%8d%ef%bc%9a%e4%b8%80%e9%a1%b9%e9%98%b4%e6%80%a7%e4%bc%98%e6%95%88%e6%80%a7%e8%af%95/Medxy AIzh2026-06-16T00:57:56-07:00急性眩晕后的数字化前庭康复：一项阴性优效性试验意味着什么 https://news.medxy.ai/digital-vestibular-rehabilitation-after-acute-vertigo-what-a-negative-superiority-trial-means/Medxy AIen2026-06-16T00:57:50-07:00Digital Vestibular Rehabilitation After Acute Vertigo: What a Negative Superiority Trial Means https://news.medxy.ai/ja/%e3%82%af%e3%83%83%e3%82%b7%e3%83%b3%e3%82%b0%e7%97%87%e5%80%99%e7%be%a4%e3%81%ae%e5%9b%9e%e5%be%a9%e3%82%92%e5%b7%a6%e5%8f%b3%e3%81%99%e3%82%8b%e3%81%ae%e3%81%af%e3%82%b3%e3%83%ab%e3%83%81%e3%82%be/Medxy AIja2026-06-15T21:02:22-07:00クッシング症候群の回復を左右するのはコルチゾールの日内リズムかもしれない https://news.medxy.ai/vi/khoi-phuc-nhip-cortisol-co-the-la-chia-khoa-cho-hoi-phuc-sau-hoi-chung-cushing/Medxy AIvi2026-06-15T21:01:46-07:00Khôi phục nhịp cortisol có thể là chìa khóa cho hồi phục sau hội chứng Cushing https://news.medxy.ai/restoring-cortisol-rhythm-may-be-key-to-recovery-after-cushing-syndrome/Medxy AIen2026-06-15T20:59:31-07:00Restoring Cortisol Rhythm May Be Key to Recovery After Cushing Syndrome https://news.medxy.ai/zh/1%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e5%85%8d%e7%96%ab%e6%b2%bb%e7%96%97%e9%95%bf%e6%9c%9f%e9%9a%8f%e8%ae%bf%ef%bc%9a%e5%ae%89%e5%85%a8%e6%80%a7%e4%bf%a1%e5%8f%b7%e6%80%bb%e4%bd%93%e4%bb%a4%e4%ba%ba/Medxy AIzh2026-06-15T20:58:00-07:001型糖尿病免疫治疗长期随访：安全性信号总体令人安心 https://news.medxy.ai/ja/1%e5%9e%8b%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%ae%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e8%a9%a6%e9%a8%93%e3%80%81%e9%95%b7%e6%9c%9f%e8%bf%bd%e8%b7%a1%e3%81%a7%e5%ae%89%e5%85%a8%e6%80%a7%e3%81%ab%e5%ae%89/Medxy AIja2026-06-15T20:57:38-07:001型糖尿病の免疫療法試験、長期追跡で安全性に安心材料 https://news.medxy.ai/vi/theo-doi-dai-han-cac-thu-nghiem-lieu-phap-mien-dich-trong-dai-thao-duong-type-1-cho-thay-tin-hieu-an-toan-dang-an-tam/Medxy AIvi2026-06-15T20:57:14-07:00Theo dõi dài hạn các thử nghiệm liệu pháp miễn dịch trong đái tháo đường type 1 cho thấy tín hiệu an toàn đáng an tâm https://news.medxy.ai/long-term-follow-up-of-type-1-diabetes-immunotherapy-trials-finds-reassuring-safety-signals/Medxy AIen2026-06-15T20:56:11-07:00Long-term Follow-up of Type 1 Diabetes Immunotherapy Trials Finds Reassuring Safety Signals https://news.medxy.ai/long-term-safety-signals-remain-reassuring-in-type-1-diabetes-immunotherapy-follow-up/Medxy AIen2026-06-15T20:42:00-07:00Long-Term Safety Signals Remain Reassuring in Type 1 Diabetes Immunotherapy Follow-up https://news.medxy.ai/vi/cuu-van-ty-the-trong-hfpef-elamipretide-phuc-hoi-chuc-nang-co-xuong-o-mo-hinh-chuot/Medxy AIvi2026-06-15T20:05:29-07:00Cứu vãn ty thể trong HFpEF: Elamipretide phục hồi chức năng cơ xương ở mô hình chuột https://news.medxy.ai/mitochondrial-rescue-in-hfpef-elamipretide-restores-skeletal-muscle-performance-in-a-rat-model/Medxy AIen2026-06-15T20:04:26-07:00Mitochondrial Rescue in HFpEF: Elamipretide Restores Skeletal Muscle Performance in a Rat Model https://news.medxy.ai/elamipretide-restores-skeletal-muscle-performance-in-a-hfpef-rat-model-by-stabilizing-mitochondria/Medxy AIen2026-06-15T20:01:19-07:00Elamipretide Restores Skeletal Muscle Performance in a HFpEF Rat Model by Stabilizing Mitochondria https://news.medxy.ai/can-a-mitochondrial-membrane-stabilizer-restore-muscle-function-in-hfpef-new-rat-data-on-elamipretide/Medxy AIen2026-06-15T19:59:27-07:00Can a Mitochondrial “Membrane Stabilizer” Restore Muscle Function in HFpEF? New Rat Data on Elamipretide https://news.medxy.ai/cardiolipin-stabilization-revives-skeletal-muscle-performance-in-a-preclinical-hfpef-model/Medxy AIen2026-06-15T19:57:53-07:00Cardiolipin Stabilization Revives Skeletal Muscle Performance in a Preclinical HFpEF Model https://news.medxy.ai/zh/%e8%81%9a%e7%84%a6%e5%a6%8a%e5%a8%a0%e7%9b%b8%e5%85%b3-scad%ef%bc%9aiscad-registry-%e6%8f%ad%e7%a4%ba%e5%a5%b3%e6%80%a7-mi-%e7%9a%84%e7%bd%95%e8%a7%81%e9%ab%98%e9%a3%8e%e9%99%a9%e7%97%85%e5%9b%a0/Medxy AIzh2026-06-15T19:35:49-07:00聚焦妊娠相关 SCAD：iSCAD Registry 揭示女性 MI 的罕见高风险病因 https://news.medxy.ai/ja/%e5%a6%8a%e5%a8%a0%e9%96%a2%e9%80%a3scad%e3%82%92%e8%aa%ad%e3%81%bf%e8%a7%a3%e3%81%8f%ef%bc%9aiscad-registry%e3%81%8c%e7%a4%ba%e3%81%99%e3%80%81%e5%a5%b3%e6%80%a7%e3%81%aemi%e3%81%ae%e3%81%be%e3%82%8c/Medxy AIja2026-06-15T19:35:22-07:00妊娠関連SCADを読み解く：iSCAD Registryが示す、女性のMIのまれで重大な原因 https://news.medxy.ai/vi/scad-lien-quan-den-thai-ky-iscad-registry-cho-thay-dieu-gi-ve-mot-nguyen-nhan-hiem-nhung-nguy-co-cao-gay-nhoi-mau-co-tim-o-phu-nu/Medxy AIvi2026-06-15T19:34:52-07:00SCAD liên quan đến thai kỳ: iSCAD Registry cho thấy điều gì về một nguyên nhân hiếm nhưng nguy cơ cao gây nhồi máu cơ tim ở phụ nữ https://news.medxy.ai/pregnancy-associated-scad-in-focus-what-the-iscad-registry-reveals-about-a-rare-but-high-stakes-cause-of-mi-in-women/Medxy AIen2026-06-15T19:33:41-07:00Pregnancy-Associated SCAD in Focus: What the iSCAD Registry Reveals About a Rare but High-Stakes Cause of MI in Women https://news.medxy.ai/zh/%e8%a1%80%e6%b6%b2dna%e7%94%b2%e5%9f%ba%e5%8c%96%e5%8f%af%e6%8f%8f%e7%bb%98%e5%a4%9a%e8%a1%80%e7%ae%a1%e5%ba%8a%e5%8a%a8%e8%84%89%e7%b2%a5%e6%a0%b7%e7%a1%ac%e5%8c%96%ef%bc%9a%e4%bf%a1%e5%8f%b7/Medxy AIzh2026-06-15T19:21:14-07:00血液DNA甲基化可描绘多血管床动脉粥样硬化：信号强烈，但更多反映累积风险暴露 https://news.medxy.ai/ja/%e8%a1%80%e6%b6%b2dna%e3%83%a1%e3%83%81%e3%83%ab%e5%8c%96%e3%81%af%e8%a1%80%e7%ae%a1%e5%ba%8a%e3%82%92%e3%81%be%e3%81%9f%e3%81%84%e3%81%a7%e3%82%a2%e3%83%86%e3%83%ad%e3%83%bc%e3%83%a0%e6%80%a7/Medxy AIja2026-06-15T19:20:47-07:00血液DNAメチル化は血管床をまたいでアテローム性動脈硬化症を映し出す――強いシグナルの裏にあるのは、主として累積リスク曝露の記録 https://news.medxy.ai/vi/ban-do-methyl-hoa-dna-trong-mau-phan-anh-xo-vua-dong-mach-o-nhieu-giuong-mach-tin-hieu-manh-nhung-chu-yeu-la-dau-vet-cua-phoi-nhiem-nguy-co-tich-luy/Medxy AIvi2026-06-15T19:20:15-07:00Bản đồ methyl hóa DNA trong máu phản ánh xơ vữa động mạch ở nhiều giường mạch: tín hiệu mạnh, nhưng chủ yếu là dấu vết của phơi nhiễm nguy cơ tích lũy https://news.medxy.ai/blood-dna-methylation-maps-atherosclerosis-across-vascular-beds-strong-signals-but-mostly-a-record-of-cumulative-risk-exposure/Medxy AIen2026-06-15T19:18:43-07:00Blood DNA Methylation Maps Atherosclerosis Across Vascular Beds: Strong Signals, but Mostly a Record of Cumulative Risk Exposure https://news.medxy.ai/zh/%e8%a5%bf%e7%bd%97%e8%8e%ab%e5%8f%b8%e6%b4%97%e8%84%b1%e7%90%83%e5%9b%8a%e8%83%bd%e5%90%a6%e5%87%8f%e5%b0%91%e6%96%b0%e5%8f%91%e5%86%a0%e7%8a%b6%e5%8a%a8%e8%84%89%e7%97%85%e5%8f%98%e4%b8%ad%e7%9a%84/Medxy AIzh2026-06-15T18:49:42-07:00西罗莫司洗脱球囊能否减少新发冠状动脉病变中的支架使用？SELUTION DeNovo 随机研究带来新证据 https://news.medxy.ai/ja/%e6%96%b0%e8%a6%8f%e5%86%a0%e5%8b%95%e8%84%88%e7%97%85%e5%a4%89%e3%81%a7%e3%82%b9%e3%83%86%e3%83%b3%e3%83%88%e4%bd%bf%e7%94%a8%e3%82%92%e6%b8%9b%e3%82%89%e3%81%9b%e3%82%8b%e3%81%8b%ef%bc%9f-selution-d/Medxy AIja2026-06-15T18:49:19-07:00新規冠動脈病変でステント使用を減らせるか？ SELUTION DeNovoが示したシロリムス溶出バルーンの新たなランダム化エビデンス https://news.medxy.ai/vi/bong-phong-thich-sirolimus-co-the-giam-nhu-cau-dung-stent-trong-benh-mach-vanh-nguyen-phat-khong-bang-chung-ngau-nhien-moi-tu-selution-denovo/Medxy AIvi2026-06-15T18:48:55-07:00Bóng phóng thích sirolimus có thể giảm nhu cầu dùng stent trong bệnh mạch vành nguyên phát không? Bằng chứng ngẫu nhiên mới từ SELUTION DeNovo https://news.medxy.ai/can-a-sirolimus-eluting-balloon-reduce-stent-use-in-de-novo-coronary-disease-new-randomized-evidence-from-selution-denovo/Medxy AIen2026-06-15T18:47:50-07:00Can a Sirolimus-Eluting Balloon Reduce Stent Use in De Novo Coronary Disease? New Randomized Evidence from SELUTION DeNovo https://news.medxy.ai/ja/%e6%96%b0%e8%a6%8f%e5%86%a0%e5%8b%95%e8%84%88%e7%97%85%e5%a4%89%e3%81%a7sirolimus%e6%ba%b6%e5%87%ba%e3%83%90%e3%83%ab%e3%83%bc%e3%83%b3%e3%81%af%e3%83%ab%e3%83%bc%e3%83%81%e3%83%b3%e3%82%b9%e3%83%86/Medxy AIja2026-06-15T18:43:24-07:00新規冠動脈病変でSirolimus溶出バルーンはルーチンステントに並び得るか？ 新たなランダム化試験は「可能性あり」と示唆 https://news.medxy.ai/vi/bong-phu-sirolimus-co-the-canh-tranh-voi-dat-stent-thuong-quy-trong-ton-thuong-dong-mach-vanh-de-novo-khong-mot-thu-nghiem-ngau-nhien-moi-cho-thay-co-the-la-co/Medxy AIvi2026-06-15T18:42:59-07:00Bóng phủ sirolimus có thể cạnh tranh với đặt stent thường quy trong tổn thương động mạch vành de novo không? Một thử nghiệm ngẫu nhiên mới cho thấy: có thể là có https://news.medxy.ai/can-a-sirolimus-eluting-balloon-strategy-rival-routine-stenting-in-de-novo-coronary-lesions-new-randomized-trial-says-maybe/Medxy AIen2026-06-15T18:41:43-07:00Can a Sirolimus-Eluting Balloon Strategy Rival Routine Stenting in De Novo Coronary Lesions? New Randomized Trial Says Maybe https://news.medxy.ai/zh/%e9%98%bf%e7%bb%b4%e9%b2%81%e5%8d%95%e6%8a%97%e9%81%87%e4%b8%8a%e7%94%b2%e6%b0%a8%e8%9d%b6%e5%91%a4%ef%bc%9a%e4%bd%8e%e9%a3%8e%e9%99%a9%e5%a6%8a%e5%a8%a0%e6%bb%8b%e5%85%bb%e7%bb%86%e8%83%9e%e8%82%bf/Medxy AIzh2026-06-15T18:33:21-07:00阿维鲁单抗遇上甲氨蝶呤：低风险妊娠滋养细胞肿瘤的一线治疗新希望 https://news.medxy.ai/ja/%e4%bd%8e%e3%83%aa%e3%82%b9%e3%82%af%e5%a6%8a%e5%a8%a0%e6%80%a7%e7%b5%a8%e6%af%9b%e6%80%a7%e8%85%ab%e7%98%8d%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e6%9c%89%e6%9c%9b%e3%81%aa%e4%b8%80%e6%ac%a1%e6%b2%bb/Medxy AIja2026-06-15T18:33:01-07:00低リスク妊娠性絨毛性腫瘍に対する有望な一次治療：AvelumabとMethotrexateの併用 https://news.medxy.ai/vi/avelumab-phoi-hop-methotrexate-chien-luoc-dieu-tri-buoc-dau-day-trien-vong-cho-u-nguyen-bao-nuoi-thai-ky-nguy-co-thap/Medxy AIvi2026-06-15T18:32:39-07:00Avelumab phối hợp methotrexate: chiến lược điều trị bước đầu đầy triển vọng cho u nguyên bào nuôi thai kỳ nguy cơ thấp https://news.medxy.ai/avelumab-meets-methotrexate-a-promising-first-line-strategy-for-low-risk-gestational-trophoblastic-tumors/Medxy AIen2026-06-15T18:31:23-07:00Avelumab Meets Methotrexate: A Promising First-Line Strategy for Low-Risk Gestational Trophoblastic Tumors https://news.medxy.ai/avelumab-plus-methotrexate-in-low-risk-gestational-trophoblastic-tumors-a-promising-first-line-signal-from-trophamet/Medxy AIen2026-06-15T18:09:41-07:00Avelumab Plus Methotrexate in Low-Risk Gestational Trophoblastic Tumors: A Promising First-Line Signal From TROPHAMET